There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

world

This magazine is from a federated server and may be incomplete. Browse more on the original instance.

The first drug that slows Alzheimer's has finally received FDA approval (www.engadget.com)

Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines